Lesson plan
1Fe-LSD
1Fe-LSD, also known as 1-(ferrocenecarbonyl)-LSD or as SYN-L-234, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to be a prodrug of LSD. The drug was patented by Lizard Labs in 2024. Subsequently, it was encountered online as a novel designer drug being sold in Germany in November 2025. 1Fe-LSD as the hemi- L -tartrate salt has been sold in the form of blotter containing 200 μg per tab and micropills containing 300 μg per pill. 1Fe-LSD is not an explicitly controlled substance in the United States or in Canada. 1Fe-LSD contains ferrocenyl, an iron substituent. Ferrocene is an orange organometallic compound and its attachment to the LSD molecule is assumed to result in the distinctive orange color of 1Fe-LSD blotter and pills.
Article summary
1Fe-LSD, also known as 1-(ferrocenecarbonyl)-LSD or as SYN-L-234, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to be a prodrug of LSD. The drug was patented by Lizard Labs in 2024. Subsequently, it was encountered online as a novel designer drug being sold in Germany in November 2025. 1Fe-LSD as the hemi- L -tartrate salt has been sold in the form of blotter containing 200 μg per tab and micropills containing 300 μg per pill. 1Fe-LSD is not an explicitly controlled substance in the United States or in Canada. 1Fe-LSD contains ferrocenyl, an iron substituent. Ferrocene is an orange organometallic compound and its attachment to the LSD molecule is assumed to result in the distinctive orange color of 1Fe-LSD blotter and pills.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.